UniProt ID | SIGL7_HUMAN | |
---|---|---|
UniProt AC | Q9Y286 | |
Protein Name | Sialic acid-binding Ig-like lectin 7 | |
Gene Name | SIGLEC7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 467 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein. |
|
Protein Description | Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acid. Also binds disialogangliosides (disialogalactosyl globoside, disialyl lactotetraosylceramide and disialyl GalNAc lactotetraoslylceramide). The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Mediates inhibition of natural killer cells cytotoxicity. May play a role in hemopoiesis. Inhibits differentiation of CD34+ cell precursors towards myelomonocytic cell lineage and proliferation of leukemic myeloid cells (in vitro).. | |
Protein Sequence | MLLLLLLPLLWGRERVEGQKSNRKDYSLTMQSSVTVQEGMCVHVRCSFSYPVDSQTDSDPVHGYWFRAGNDISWKAPVATNNPAWAVQEETRDRFHLLGDPQTKNCTLSIRDARMSDAGRYFFRMEKGNIKWNYKYDQLSVNVTALTHRPNILIPGTLESGCFQNLTCSVPWACEQGTPPMISWMGTSVSPLHPSTTRSSVLTLIPQPQHHGTSLTCQVTLPGAGVTTNRTIQLNVSYPPQNLTVTVFQGEGTASTALGNSSSLSVLEGQSLRLVCAVDSNPPARLSWTWRSLTLYPSQPSNPLVLELQVHLGDEGEFTCRAQNSLGSQHVSLNLSLQQEYTGKMRPVSGVLLGAVGGAGATALVFLSFCVIFIVVRSCRKKSARPAADVGDIGMKDANTIRGSASQGNLTESWADDNPRHHGLAAHSSGEEREIQYAPLSFHKGEPQDLSGQEATNNEYSEIKIPK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
105 | N-linked_Glycosylation | LGDPQTKNCTLSIRD CCCCCCCCCEEEEEE | 27.65 | 16895906 | |
109 | Phosphorylation | QTKNCTLSIRDARMS CCCCCEEEEEEECHH | 9.45 | 24719451 | |
142 | N-linked_Glycosylation | KYDQLSVNVTALTHR EECEEEEEEEEECCC | 23.26 | UniProtKB CARBOHYD | |
165 | N-linked_Glycosylation | LESGCFQNLTCSVPW CCCCCCCCCEECCCC | 19.64 | UniProtKB CARBOHYD | |
229 | N-linked_Glycosylation | PGAGVTTNRTIQLNV CCCCCEECCEEEEEE | 29.72 | UniProtKB CARBOHYD | |
235 | N-linked_Glycosylation | TNRTIQLNVSYPPQN ECCEEEEEEECCCCC | 12.33 | UniProtKB CARBOHYD | |
242 | N-linked_Glycosylation | NVSYPPQNLTVTVFQ EEECCCCCEEEEEEE | 43.37 | UniProtKB CARBOHYD | |
260 | N-linked_Glycosylation | TASTALGNSSSLSVL CCEEECCCCCCEEEE | 39.30 | UniProtKB CARBOHYD | |
334 | N-linked_Glycosylation | GSQHVSLNLSLQQEY CCCEEEEEEEEEEHH | 21.78 | UniProtKB CARBOHYD | |
349 | Phosphorylation | TGKMRPVSGVLLGAV CCCCCCCCCEEHHCC | 26.35 | - | |
362 | Phosphorylation | AVGGAGATALVFLSF CCCHHHHHHHHHHHH | 21.43 | - | |
400 | Phosphorylation | IGMKDANTIRGSASQ CCCCCCCCCCCCCCC | 17.48 | 27486199 | |
404 | Phosphorylation | DANTIRGSASQGNLT CCCCCCCCCCCCCCC | 18.20 | 26657352 | |
406 | Phosphorylation | NTIRGSASQGNLTES CCCCCCCCCCCCCCC | 40.07 | 28355574 | |
411 | Phosphorylation | SASQGNLTESWADDN CCCCCCCCCCCCCCC | 31.79 | 28450419 | |
413 | Phosphorylation | SQGNLTESWADDNPR CCCCCCCCCCCCCCC | 23.48 | 28450419 | |
428 | Phosphorylation | HHGLAAHSSGEEREI CCCCCCCCCCCCEEE | 35.00 | 24275569 | |
429 | Phosphorylation | HGLAAHSSGEEREIQ CCCCCCCCCCCEEEE | 40.12 | 16895906 | |
437 | Phosphorylation | GEEREIQYAPLSFHK CCCEEEEEECCEECC | 18.82 | 28258704 | |
441 | Phosphorylation | EIQYAPLSFHKGEPQ EEEEECCEECCCCCC | 25.01 | 28258704 | |
460 | Phosphorylation | QEATNNEYSEIKIPK CCCCCCCCCCCCCCC | 17.46 | 25587033 | |
461 | Phosphorylation | EATNNEYSEIKIPK- CCCCCCCCCCCCCC- | 27.02 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SIGL7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SIGL7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LG3BP_HUMAN | LGALS3BP | physical | 25320078 | |
WDR89_HUMAN | WDR89 | physical | 28514442 | |
LEG1_HUMAN | LGALS1 | physical | 28514442 | |
PTN6_HUMAN | PTPN6 | physical | 15703304 | |
PTN11_HUMAN | PTPN11 | physical | 15703304 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Siglec-7 undergoes a major conformational change when complexed withthe alpha(2,8)-disialylganglioside GT1b."; Attrill H., Imamura A., Sharma R.S., Kiso M., Crocker P.R.,van Aalten D.M.; J. Biol. Chem. 281:32774-32783(2006). Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 18-144 IN COMPLEX WITHALPHA(2,8)-DISIALYLATED LIGAND GT1B, GLYCOSYLATION AT ASN-105, ANDDISULFIDE BOND. | |
"The structure of siglec-7 in complex with sialosides: leads forrational structure-based inhibitor design."; Attrill H., Takazawa H., Witt S., Kelm S., Isecke R., Brossmer R.,Ando T., Ishida H., Kiso M., Crocker P.R., van Aalten D.M.; Biochem. J. 397:271-278(2006). Cited for: X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 18-144 IN COMPLEX WITHSIALYLATED LIGAND, GLYCOSYLATION AT ASN-105, AND DISULFIDE BOND. |